Kidney TransplantationTransplantation, HomologousLiver TransplantationGraft SurvivalGraft RejectionImmunosuppressive AgentsBone Marrow TransplantationHematopoietic Stem Cell TransplantationHeart TransplantationTransplantation, AutologousTime FactorsLung TransplantationStem Cell TransplantationTransplantation ConditioningOrgan TransplantationPancreas TransplantationIslets of Langerhans TransplantationTissue DonorsTransplantationTransplantation ImmunologyCell TransplantationTransplantation ChimeraGraft vs Host DiseaseTransplantation, IsogeneicTreatment OutcomeLiving DonorsTransplantation, HeterotopicCord Blood Stem Cell TransplantationHeart-Lung TransplantationTissue and Organ ProcurementTransplantation TolerancePeripheral Blood Stem Cell TransplantationRetrospective StudiesLiver FailureImmunosuppressionHistocompatibility TestingFetal Tissue TransplantationPostoperative ComplicationsSkin TransplantationWaiting ListsRecurrenceTransplantation, HeterologousMesenchymal Stem Cell TransplantationCorneal TransplantationHistocompatibilityHematologic NeoplasmsTacrolimusTissue TransplantationCyclosporineWhole-Body IrradiationFollow-Up StudiesCadaverSurvival AnalysisSurvival RateBrain Tissue TransplantationFacial TransplantationDonor SelectionLiver DiseasesPost and Core TechniqueOrgan PreservationBusulfanTransplantsKidney Failure, ChronicHLA AntigensLeukemiaCombined Modality TherapyRisk FactorsBronchiolitis ObliteransAntilymphocyte SerumPostoperative PeriodAnemia, AplasticRemission InductionCytomegalovirus InfectionsHand TransplantationAcute DiseaseMycophenolic AcidBlood Group IncompatibilityMyeloablative AgonistsMice, Inbred C57BLHematopoietic Stem CellsTissue and Organ HarvestingRats, Inbred LewPrognosisCyclophosphamideEnd Stage Liver DiseaseLiverPatient SelectionProspective StudiesNeoplasm TransplantationDisease-Free SurvivalBrain DeathMelphalanLiver Failure, AcuteMultiple MyelomaT-LymphocytesCell DifferentiationPrimary Graft DysfunctionChimerismABO Blood-Group SystemLiver Cirrhosis